A new capsule that can reduce hospitalizations by half due to covid


An American scientist has developed a new capsule that can reduce the number of hospitalizations caused by the Kovid virus by half.

Named Molnupiravir, it was administered to Kovid patients in two capsules a day.

The company said the results were “extremely successful” and that the product had already been applied for emergency use.

In a study of 775 people, only 7.3% had symptoms that led to hospitalization.

No deaths were reported.

Several companies including Pfizer have already started producing coils but have not yet achieved any successful results.

You might also like
Leave a comment